ASIA-话题@MedSci

#ASIA#

71篇内容 | 866人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1780077, encodeId=9b9e1e8007769, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac Allergy：永久性过敏性鼻炎患者中，血清25-羟甲基维生素D与血嗜酸细胞负相关, objectType=article, longId=119501, objectId=dc21119501c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc21119501c3, replyNumber=0, likeNumber=33, createdTime=2018-07-13, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc21119501c3, moduleTitle=Asia Pac Allergy：永久性过敏性鼻炎患者中，血清25-羟甲基维生素D与血嗜酸细胞负相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc21119501c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780093, encodeId=f0291e80093b3, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac Fam Med:香港学者研究称，中国六至八成医生职业倦怠, objectType=article, longId=136795, objectId=c5cf136e959d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c5cf136e959d, replyNumber=0, likeNumber=45, createdTime=2019-03-29, rootId=0, userName=hb2008ye, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c5cf136e959d, moduleTitle=Asia Pac Fam Med:香港学者研究称，中国六至八成医生职业倦怠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c5cf136e959d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780085, encodeId=953f1e80085a4, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO Asia】FLAURA研究：奥希替尼显著延长PFS及ORR, objectType=article, longId=120734, objectId=3f0d120e34d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f0d120e34d1, replyNumber=0, likeNumber=32, createdTime=2018-01-24, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f0d120e34d1, moduleTitle=【ESMO Asia】FLAURA研究：奥希替尼显著延长PFS及ORR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f0d120e34d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780092, encodeId=7b1b1e80092b5, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：患有或不患有过敏性鼻炎的哮喘儿童中，Th17细胞调控的免疫应答比较, objectType=article, longId=134463, objectId=542f134463ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=542f134463ff, replyNumber=0, likeNumber=32, createdTime=2018-08-06, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=542f134463ff, moduleTitle=Asian Pac J Allergy Immunol：患有或不患有过敏性鼻炎的哮喘儿童中，Th17细胞调控的免疫应答比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=542f134463ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780080, encodeId=b2331e8008067, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian J Psychia：耳鸣还是幻听？如何区分？如何治疗？, objectType=article, longId=120682, objectId=f966120682ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f966120682ce, replyNumber=0, likeNumber=33, createdTime=2018-08-25, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f966120682ce, moduleTitle=Asian J Psychia：耳鸣还是幻听？如何区分？如何治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f966120682ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780076, encodeId=3fe51e8007627, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=NPG Asia Mater：深圳先进院二维材料肿瘤靶向放疗研究获进展, objectType=article, longId=119420, objectId=ef5711942088, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef5711942088, replyNumber=0, likeNumber=36, createdTime=2018-08-06, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef5711942088, moduleTitle=NPG Asia Mater：深圳先进院二维材料肿瘤靶向放疗研究获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef5711942088)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780071, encodeId=38521e800711a, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian J Psychiat: 抗精神病药导致的恶性综合征需要更广泛的诊断标准, objectType=article, longId=113002, objectId=8b0c11300218, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b0c11300218, replyNumber=0, likeNumber=30, createdTime=2018-06-20, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b0c11300218, moduleTitle=Asian J Psychiat: 抗精神病药导致的恶性综合征需要更广泛的诊断标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b0c11300218)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780082, encodeId=a3941e80082b0, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO Asia】FLAURA研究：奥希替尼显著降低脑转移患者进展和死亡风险, objectType=article, longId=120687, objectId=615212068e26, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=615212068e26, replyNumber=0, likeNumber=39, createdTime=2017-12-28, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=615212068e26, moduleTitle=【ESMO Asia】FLAURA研究：奥希替尼显著降低脑转移患者进展和死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=615212068e26)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780073, encodeId=42231e8007302, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Neoplasia：“良好”肠道菌群，与黑素瘤免疫治疗相关！, objectType=article, longId=115735, objectId=56da115e3542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56da115e3542, replyNumber=0, likeNumber=32, createdTime=2018-06-12, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56da115e3542, moduleTitle=Neoplasia：“良好”肠道菌群，与黑素瘤免疫治疗相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56da115e3542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780083, encodeId=56cc1e800836d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO ASIA 2017】阿昔替尼一线治疗亚洲人群数据发布, objectType=article, longId=120732, objectId=7aba120e32fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aba120e32fd, replyNumber=0, likeNumber=38, createdTime=2018-07-28, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aba120e32fd, moduleTitle=【ESMO ASIA 2017】阿昔替尼一线治疗亚洲人群数据发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aba120e32fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780088, encodeId=70531e80088ba, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位, objectType=article, longId=121278, objectId=c84a1212e86d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c84a1212e86d, replyNumber=0, likeNumber=28, createdTime=2018-03-23, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c84a1212e86d, moduleTitle=【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c84a1212e86d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780090, encodeId=b9c01e800902d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asian Pac J Allergy Immunol：哮喘和/或过敏性鼻炎儿童中，大洪水和高空过敏症敏感性分析, objectType=article, longId=122161, objectId=70581221610c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70581221610c, replyNumber=0, likeNumber=26, createdTime=2018-01-07, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70581221610c, moduleTitle=Asian Pac J Allergy Immunol：哮喘和/或过敏性鼻炎儿童中，大洪水和高空过敏症敏感性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70581221610c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780068, encodeId=731a1e800681d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=NEOPLASIA：癌细胞会隐身，传播癌症“肆无忌惮”, objectType=article, longId=94234, objectId=fd499423418, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd499423418, replyNumber=0, likeNumber=30, createdTime=2017-12-20, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd499423418, moduleTitle=NEOPLASIA：癌细胞会隐身，传播癌症“肆无忌惮”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd499423418)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780070, encodeId=e5221e80070a8, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Heart Asia：妊娠并发症增加后代心脏病风险！, objectType=article, longId=99720, objectId=7e3a99e20b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e3a99e20b6, replyNumber=0, likeNumber=36, createdTime=2017-07-12, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e3a99e20b6, moduleTitle=Heart Asia：妊娠并发症增加后代心脏病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e3a99e20b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780072, encodeId=7dd21e800722d, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Neoplasia：研究锁定免疫疗法的“功臣”，有了它们，抗癌显著倍增！, objectType=article, longId=115295, objectId=f05111529542, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f05111529542, replyNumber=0, likeNumber=28, createdTime=2018-07-06, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f05111529542, moduleTitle=Neoplasia：研究锁定免疫疗法的“功臣”，有了它们，抗癌显著倍增！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f05111529542)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780069, encodeId=e6ff1e8006921, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=CAOS2017学术 | ASIA关节精英国际课程虚位以待, objectType=article, longId=94767, objectId=c4fb94e6734, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4fb94e6734, replyNumber=0, likeNumber=50, createdTime=2017-07-23, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4fb94e6734, moduleTitle=CAOS2017学术 | ASIA关节精英国际课程虚位以待, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4fb94e6734)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780067, encodeId=1d8d1e8006703, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=ESMO ASIA 2016：辉瑞突破性乳腺癌药物Ibrance在亚洲ER+/HER2-转移性乳腺癌患者中疗效显著, objectType=article, longId=85001, objectId=ab7e85001cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab7e85001cf, replyNumber=0, likeNumber=39, createdTime=2017-09-19, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab7e85001cf, moduleTitle=ESMO ASIA 2016：辉瑞突破性乳腺癌药物Ibrance在亚洲ER+/HER2-转移性乳腺癌患者中疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab7e85001cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780066, encodeId=356e1e80066bb, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=ESMO Asia 2015：帕布昔利布(palbociclib)+氟维司群治疗亚洲HR+/HER2-晚期乳腺癌女性疗效佳（PALOMA3试验亚洲结果）, objectType=article, longId=60863, objectId=28b16086327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28b16086327, replyNumber=0, likeNumber=31, createdTime=2016-04-13, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28b16086327, moduleTitle=ESMO Asia 2015：帕布昔利布(palbociclib)+氟维司群治疗亚洲HR+/HER2-晚期乳腺癌女性疗效佳（PALOMA3试验亚洲结果）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28b16086327)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780064, encodeId=67991e8006455, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=Asia Pac Psychiatry：越穷，越容易抑郁？, objectType=article, longId=55493, objectId=1125554933d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1125554933d, replyNumber=0, likeNumber=29, createdTime=2016-07-01, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1125554933d, moduleTitle=Asia Pac Psychiatry：越穷，越容易抑郁？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1125554933d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780065, encodeId=cf361e8006520, content=<a href='/topic/show?id=10d62860dd' target=_blank style='color:#2F92EE;'>#ASIA#</a>, objectTitle=MedSci参加 2015 Asia Pacific Meeting of ISMPP, objectType=article, longId=55706, objectId=af4355e06da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4355e06da, replyNumber=0, likeNumber=13, createdTime=2015-11-01, rootId=0, userName=luwei00, userId=e093393, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4355e06da, moduleTitle=MedSci参加 2015 Asia Pacific Meeting of ISMPP, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4355e06da)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ASIA

2020-05-29

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac Allergy：永久性过敏性鼻炎患者中，血清25-羟甲基维生素D与血嗜酸细胞负相关

2018-07-13

hb2008ye (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac Fam Med:香港学者研究称，中国六至八成医生职业倦怠

2019-03-29

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO Asia】FLAURA研究：奥希替尼显著延长PFS及ORR

2018-01-24

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：患有或不患有过敏性鼻炎的哮喘儿童中，Th17细胞调控的免疫应答比较

2018-08-06

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian J Psychia：耳鸣还是幻听？如何区分？如何治疗？

2018-08-25

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

NPG Asia Mater：深圳先进院二维材料肿瘤靶向放疗研究获进展

2018-08-06

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian J Psychiat: 抗精神病药导致的恶性综合征需要更广泛的诊断标准

2018-06-20

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO Asia】FLAURA研究：奥希替尼显著降低脑转移患者进展和死亡风险

2017-12-28

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Neoplasia：“良好”肠道菌群，与黑素瘤免疫治疗相关！

2018-06-12

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO ASIA 2017】阿昔替尼一线治疗亚洲人群数据发布

2018-07-28

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

【ESMO Asia】FLAURA研究奠定奥希替尼一线标准治疗地位

2018-03-23

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asian Pac J Allergy Immunol：哮喘和/或过敏性鼻炎儿童中，大洪水和高空过敏症敏感性分析

2018-01-07

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

NEOPLASIA：癌细胞会隐身，传播癌症“肆无忌惮”

2017-12-20

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Heart Asia：妊娠并发症增加后代心脏病风险！

2017-07-12

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Neoplasia：研究锁定免疫疗法的“功臣”，有了它们，抗癌显著倍增！

2018-07-06

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

CAOS2017学术 | ASIA关节精英国际课程虚位以待

2017-07-23

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

ESMO ASIA 2016：辉瑞突破性乳腺癌药物Ibrance在亚洲ER+/HER2-转移性乳腺癌患者中疗效显著

2017-09-19

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

ESMO Asia 2015：帕布昔利布(palbociclib)+氟维司群治疗亚洲HR+/HER2-晚期乳腺癌女性疗效佳（PALOMA3试验亚洲结果）

2016-04-13

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

Asia Pac Psychiatry：越穷，越容易抑郁？

2016-07-01

luwei00 (审核中...)

前往app查看评论内容

#ASIA#

MedSci参加 2015 Asia Pacific Meeting of ISMPP

2015-11-01

科室
- - 订阅+
  - 更多科室
工具
服务